Skip to main content

Table 3 Distribution of EQ-5D-5L dimensions at baseline and at follow-up

From: First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study

 

All Patients

Type 2 diabetes

Chronic low back pain

Long COVID

 

Baseline (n/%)

3 mos. fu. (n/%)

Baseline (n/%)

3 mos. fu. (n/%)

Baseline (n/%)

3 mos. fu. (n/%)

Baseline (n/%)

3 mos. fu. (n/%)

Mobility

 No problem

102 (50.3)

120 (59.1)

41 (69.5)

45 (76.3)

22 (24.7)

37 (41.6)

39 (70.9)

38 (69.1)

 Any problem

101 (49.7)

83 (40.9)

18 (30.50)

14 (23.7)

67 (75.3)

52 (58.4)

16 (29.1)

17 (30.9)

 χ2

6.23

2.67

7.26

0.07

p a

.012

.219

.011

1

Self-care

 No problem

164 (80.8)

170 (83.7)

58 (98.3)

57 (96.6)

54 (60.7)

62 (69.7)

52 (94.6)

51 (92.7)

 Any problem

39 (19.2)

33 (16.3)

1 (1.7)

2 (3.4)

35 (39.3)

27 (30.3)

3 (5.4)

4 (7.3)

χ2

1.12

.033

2.91

0.14

p a

.377

1

.134

1

Usual activities

 No problem

49 (24.1)

86 (42.4)

40 (67.8)

44 (74.6)

3 (3.4)

20 (22.5)

6 (10.9)

22 (40)

 Any problem

154 (75.9)

117 (57.6)

19 (32.2)

15 (25.4)

86 (96.6)

69 (77..5)

49 (89.1)

33 (60)

 χ2

22.44

0.89

15.21

10.67

p a

< .001

.481

< .001

.002

Pain/discomfort

 No problem

19 (9.4)

24 (11.8)

12 (20.3)

15 (25.4)

0 (0)

1 (1.1)

7 (12.7)

8 (14.6)

 Any problem

184 (90.6)

179 (88.2)

47 (79.7)

44 (74.6)

89 (100)

88 (98.9)

48 (87.3)

47 (85.4)

 χ2 (df)

1.09

0.69

1

0.11

p a

.405

.581

1

1

Anxiety/depression

 No problem

85 (41.9)

99 (48.8)

37 (62.7)

37 (62.7)

33 (37.1)

41 (46.1)

15 (27.3)

21 (38.2)

 Any problem

118 (58.1)

104 (51.2)

22 (37.3)

22 (37.3)

56 (62.9)

48 (53.9)

40 (72.7)

34 (61.8)

 χ2 (df)

4.26

0.00

2.91

2.25

p a

.054

1

.134

.210

  1. The EQ-5D levels were dichotomised into “no problems” (level 1) and “any problems” (levels 2–5)
  2. aMcNemar’s exact significance probability